IBD is a core part of gastroenterology—but not every fellowship program offers the depth of exposure needed to feel confident managing complex disease. The Visiting IBD Observership (VIBD) Program was created to close that gap.Applications are now open for the Fall 2026–Spring 2027 cycl...

New global pregnancy consensus guidelines are reshaping how we counsel adolescents and young adults with IBD—well before pregnancy is on the horizon. According to REACH-IBD member Dr. Amelia Kellar (UChicago Medicine), early, proactive preconception counseling and sustained disease remi...

This content comes from the REACH-IBD Fall 2025 Newsletter, our quarterly online publication by and for early-career IBDologists.  Dr. Hassan Hamandi offers a clinical perspective on transition of care. He oversees UCLA’s Pediatric-to-Adult Transition Clinic, supporting autonomy, m...

Up to 50% of Crohn’s and ulcerative colitis patients will develop extraintestinal manifestations (EIMs), affecting joints, skin, eyes, and the liver, but EIMs don’t always track with intestinal inflammation.That means a patient can be in gut remission yet struggle with arthritis, uveiti...

For the first time, an international panel of IBD experts, maternal-fetal medicine specialists, surgeons, and patient advocates recently came together to establish global consensus guidelines for pregnancy in inflammatory bowel disease (IBD). Published simultaneously in six leading jour...

The Foundation continually strives to create meaningful partnerships and connections with healthcare professionals and institutions serving IBD patients. We are committed to keeping you, our healthcare professional partners, well-informed with timely information that helps you. Below yo...

Have you ever wondered what makes someone an inflammatory bowel disease (IBD) expert? Some have described it as, “You know one when you see one.” However, there hasn’t been a set definition of what it truly means. The Crohn’s & Colitis Foundation and the American College of Gas...